PT1047450E - Combinacoes inibidor ace - inibidor mmp - Google Patents

Combinacoes inibidor ace - inibidor mmp

Info

Publication number: PT1047450E
Authority: PT; Portugal
Prior art keywords: inhibitor; combinations; mmp; ace; ace inhibitor
Prior art date: 1997-12-23

Application number

PT98959416T

Other languages

English (en)

Inventor

Joseph Thomas Peterson Jr

Milton Lethan Pressler

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-23

Filing date

1998-11-10

Publication date

2003-02-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22083543&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1047450(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-11-10 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2003-02-28 Publication of PT1047450E publication Critical patent/PT1047450E/pt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

PT98959416T 1997-12-23 1998-11-10 Combinacoes inibidor ace - inibidor mmp PT1047450E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US6859497P	1997-12-23	1997-12-23

Publications (1)

Publication Number	Publication Date
PT1047450E true PT1047450E (pt)	2003-02-28

Family

ID=22083543

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT98959416T PT1047450E (pt)	1997-12-23	1998-11-10	Combinacoes inibidor ace - inibidor mmp

Country Status (24)

Country	Link
US (1)	US6133304A (pt)
EP (1)	EP1047450B1 (pt)
JP (1)	JP2001526245A (pt)
KR (1)	KR20010033473A (pt)
AR (1)	AR015504A1 (pt)
AT (1)	ATE225187T1 (pt)
AU (1)	AU751701B2 (pt)
BR (1)	BR9814422A (pt)
CA (1)	CA2305436A1 (pt)
CO (1)	CO4970775A1 (pt)
DE (1)	DE69808518T2 (pt)
DK (1)	DK1047450T3 (pt)
ES (1)	ES2184340T3 (pt)
HU (1)	HUP0100427A3 (pt)
IL (1)	IL135428A0 (pt)
IS (1)	IS5446A (pt)
NO (1)	NO20003256L (pt)
NZ (1)	NZ503962A (pt)
PE (1)	PE20000065A1 (pt)
PL (1)	PL341335A1 (pt)
PT (1)	PT1047450E (pt)
UY (1)	UY25321A1 (pt)
WO (1)	WO1999032150A1 (pt)
ZA (1)	ZA9811794B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR0009244A (pt) *	1999-03-03	2002-04-16	Procter & Gamble	Inibidores de metaloprotease di-hétero substituìdos
US6376524B1 (en)	2000-06-21	2002-04-23	Sunesis Pharmaceuticals, Inc.	Triphenyl compounds as interleukin-4 antagonists
GB0100761D0 (en)	2001-01-11	2001-02-21	Biocompatibles Ltd	Drug delivery from stents
KR100854424B1 (ko)	2001-01-29	2008-08-27	3-디멘져널 파마슈티칼즈 인코오포레이티드	치환된 인돌 및 인테그린 길항제로서의 이들의 용도
DE10125882B4 (de) *	2001-05-28	2007-03-29	Esparma Gmbh	Arzneimittel enthaltend Ambroxol, dessen Salze und/oder Prodrugs zusammen mit α-Liponsäure im Rahmen der Behandlung des Diabetes mellitus
WO2003015762A1 (fr) *	2001-08-20	2003-02-27	Ono Pharmaceutical Co., Ltd.	Agent therapeutique pour insuffisance cardiaque
US7071211B2 (en) *	2002-09-27	2006-07-04	Bausch & Lomb Inc.	Small organic molecules that increase the activity of gelatinase a in ocular cells
EP1545287B1 (en) *	2002-10-04	2012-12-05	THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE DEPARTMENT OF HEALTH & HUMAN SERVICES	Vasoregulating compounds and methods of their use
CA2504953C (en) *	2002-11-07	2013-08-20	The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	A new target for angiogenesis and anti-angiogenesis therapy
US20040225077A1 (en)	2002-12-30	2004-11-11	Angiotech International Ag	Drug delivery from rapid gelling polymer composition
EP1660661A2 (en) *	2003-08-08	2006-05-31	Arriva Pharmaceuticals, Inc.	Methods of protein production in yeast
SI1684719T1 (sl) *	2003-11-14	2012-07-31	Baxter Int	Sestavki alfa antitripsina in postopki zdravljenja ob uporabi takih sestavkov
AU2005221151A1 (en)	2004-03-09	2005-09-22	Arriva Pharmaceuticals, Inc.	Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
AU2005268781A1 (en) *	2004-08-02	2006-02-09	Genmedica Therapeutics Sl	Compounds for inhibiting copper-containing amine oxidases and uses thereof
CN100367956C (zh) *	2006-08-29	2008-02-13	陈俊云	用于治疗高血压的药物
JP2011525194A (ja) *	2008-06-20	2011-09-15	キネメッド，インコーポレイテッド	線維性疾患または病態を治療するための組成物
WO2010011302A1 (en) *	2008-07-22	2010-01-28	Chdi, Inc.	Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
US20120270884A1 (en) *	2009-10-01	2012-10-25	Symphony Evolution, Inc.	Methods of Treating Aneurysmal Dilatation, Blood Vessel Wall Weakness and Specifically Abdominal Aortic and Thoracic Aneurysm Using Matrix Metalloprotease-2 Inhibitors
CN106518845B (zh)	2011-08-30	2019-09-13	Chdi基金会股份有限公司	犬尿氨酸-3-单加氧酶抑制剂、药物组合物及其使用方法
BR112014004845A2 (pt)	2011-08-30	2017-04-04	Chdi Foundation Inc	pelo menos uma entidade química; pelo menos um composto; composição farmacêutica; uso de uma quantidade terapeuticamente eficaz de pelo menos uma entidade química; composição farmacêutica embalada
WO2014210062A1 (en) *	2013-06-26	2014-12-31	Stealth Peptides International, Inc.	Methods for the regulation of matrix metalloproteinase expression
SG11201700341PA (en)	2014-07-17	2017-02-27	Chdi Foundation Inc	Methods and compositions for treating hiv-related disorders
WO2017117130A1 (en)	2015-12-28	2017-07-06	The United States Of America, As Represented By The Secretary, Department Of Health & Human Services	Methods for inhibiting human immunodeficiency virus (hiv) release from infected cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE148632T1 (de) *	1990-05-11	1997-02-15	Pfizer	Synergistische therapeutische zusammensetzungen und verfahren
BR9604882A (pt) *	1995-02-10	1998-05-19	Searle & Co	Terapia de combinação de inibidor de enzima de conversão de antgiotensina e quantidade de efeito colateral reduzido de antagonista de aldosterona para tratamento de doença cardiovascular
KR20000011095A (ko) *	1996-05-17	2000-02-25	로즈 암스트롱, 크리스틴 에이. 트러트웨인	비페닐술폰아미드 매트릭스 메탈로프로테이나아제 억제제
US5756545A (en) *	1997-04-21	1998-05-26	Warner-Lambert Company	Biphenysulfonamide matrix metal alloproteinase inhibitors

1998
- 1998-11-10 ES ES98959416T patent/ES2184340T3/es not_active Expired - Lifetime
- 1998-11-10 HU HU0100427A patent/HUP0100427A3/hu unknown
- 1998-11-10 CA CA002305436A patent/CA2305436A1/en not_active Abandoned
- 1998-11-10 WO PCT/US1998/023993 patent/WO1999032150A1/en not_active Application Discontinuation
- 1998-11-10 US US09/485,253 patent/US6133304A/en not_active Expired - Fee Related
- 1998-11-10 DK DK98959416T patent/DK1047450T3/da active
- 1998-11-10 AT AT98959416T patent/ATE225187T1/de not_active IP Right Cessation
- 1998-11-10 JP JP2000525140A patent/JP2001526245A/ja active Pending
- 1998-11-10 PT PT98959416T patent/PT1047450E/pt unknown
- 1998-11-10 PL PL98341335A patent/PL341335A1/xx unknown
- 1998-11-10 AU AU15220/99A patent/AU751701B2/en not_active Ceased
- 1998-11-10 KR KR1020007006974A patent/KR20010033473A/ko not_active Application Discontinuation
- 1998-11-10 DE DE69808518T patent/DE69808518T2/de not_active Expired - Fee Related
- 1998-11-10 BR BR9814422-7A patent/BR9814422A/pt not_active IP Right Cessation
- 1998-11-10 NZ NZ503962A patent/NZ503962A/xx unknown
- 1998-11-10 EP EP98959416A patent/EP1047450B1/en not_active Expired - Lifetime
- 1998-11-10 IL IL13542898A patent/IL135428A0/xx unknown
- 1998-12-22 CO CO98076095A patent/CO4970775A1/es unknown
- 1998-12-22 ZA ZA9811794A patent/ZA9811794B/xx unknown
- 1998-12-22 PE PE1998001267A patent/PE20000065A1/es not_active Application Discontinuation
- 1998-12-22 AR ARP980106613A patent/AR015504A1/es not_active Application Discontinuation
- 1998-12-22 UY UY25321A patent/UY25321A1/es unknown
2000
- 2000-04-14 IS IS5446A patent/IS5446A/is unknown
- 2000-06-22 NO NO20003256A patent/NO20003256L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
PL341335A1 (en)	2001-04-09
AU1522099A (en)	1999-07-12
JP2001526245A (ja)	2001-12-18
DE69808518D1 (de)	2002-11-07
IL135428A0 (en)	2001-05-20
EP1047450A1 (en)	2000-11-02
BR9814422A (pt)	2000-10-10
CO4970775A1 (es)	2000-11-07
PE20000065A1 (es)	2000-02-11
NZ503962A (en)	2002-03-28
NO20003256D0 (no)	2000-06-22
IS5446A (is)	2000-04-14
WO1999032150A1 (en)	1999-07-01
EP1047450B1 (en)	2002-10-02
HUP0100427A3 (en)	2002-11-28
AR015504A1 (es)	2001-05-02
ZA9811794B (en)	1999-06-29
US6133304A (en)	2000-10-17
ES2184340T3 (es)	2003-04-01
UY25321A1 (es)	2004-07-30
AU751701B2 (en)	2002-08-22
NO20003256L (no)	2000-06-22
ATE225187T1 (de)	2002-10-15
DK1047450T3 (da)	2003-01-27
CA2305436A1 (en)	1999-07-01
HUP0100427A2 (hu)	2001-06-28
KR20010033473A (ko)	2001-04-25
DE69808518T2 (de)	2003-06-26

Publication	Publication Date	Title
NO995433D0 (no)	1999-11-05	Protease-inhibitorer
PT1047450E (pt)	2003-02-28	Combinacoes inibidor ace - inibidor mmp
DK1004669T3 (da)	2007-08-27	Hidtil ukendte differentieringsinhibitor
DK1027332T3 (da)	2004-10-04	Hidtil ukendte lactametalloproteaseinhibitorer
ID19198A (id)	1998-06-28	Inhibitor metaloprotease heterosiklik
DK0958287T3 (da)	2003-01-20	Sulfamidmetalloprotease-inhibitorer
ID18416A (id)	1998-04-09	Inhibitor metaloprotease diheterosiklik
ATE245142T1 (de)	2003-08-15	No-synthase inhibitoren
NO20002121D0 (no)	2000-04-26	Benzotiazol-protein-tyrosin-kinaseinhibitorer
NO20000464L (no)	2000-03-30	Acykliske metalloprotease-inhibitorer
LV12150A (lv)	1998-10-20	Farneziltransferazes inhibitori
FI963597A0 (fi)	1996-09-12	Isoprenyylitransferaasi-inhibiittoreita
NO972930D0 (no)	1997-06-23	Fibronectin-adhesjonsinhibitorer
FI972160A (fi)	1997-05-22	Matriisimetalloproteaasi-inhibiittorit
NO995434L (no)	1999-11-05	Proteaseinhibitorer
NO995435D0 (no)	1999-11-05	Protease-inhibitorer
NO995268D0 (no)	1999-10-28	Proteaseinhibitorer
DE29701799U1 (de)	1997-04-17	Schraubendreher
ATE252547T1 (de)	2003-11-15	Matrixmetalloproteinaseinhibitoren
DE29701800U1 (de)	1997-04-17	Schraubendreher
FI973929A (fi)	1999-04-11	WOF inhibiittori
DE29708764U1 (de)	1997-07-17	Schraubendreher
DE69828361D1 (de)	2005-02-03	Apoptose-inhibitor
DE69523450T2 (de)	2002-05-16	Inhibitor
DE69720957T2 (de)	2004-01-29	Ace-hemmer